Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
Clinical trial NCT01814865 · WITHDRAWN
Trial details
- NCT number
- NCT01814865
- Sponsor
- British Columbia Cancer Agency
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.